Bristol Myers’ cell therapy manufacturing site in Massachusetts is good to go, FDA says | Fierce Pharma

Jun 16, 2023

stem cells

With two cell therapies approved and three more in its pipeline, Bristol Myers Squibb is working to beef up its manufacturing capabilities for the complex, personalized, one-and-done medicines.

Source: Bristol Myers’ cell therapy manufacturing site in Massachusetts is good to go, FDA says | Fierce Pharma

Hire with SEC


Schedule a free consultation today to experience our innovative, industry-leading executive search and engineer recruiting hiring process firsthand.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Pin It on Pinterest